Read More Pharma Industry News Restaurant Industry News Kazia Therapeutics gets US RPDD for paxalisib in childhood brain cancer Kazia Therapeutics, an Australian biotech company, has secured the rare pediatric disease designation (RPDD) for paxalisib (formerly GDC-0084)… bypharmanewsdailyAugust 8, 2020